Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CEP85 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | IFT81 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | TMEM55B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNF547 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZSCAN18 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | DIRAS1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | SGCA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ZNF132 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | C3orf62 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | CREBBP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |